• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾源性残留(Wilms瘤的遗传前体)中WT1的失活。

Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.

作者信息

Park S, Bernard A, Bove K E, Sens D A, Hazen-Martin D J, Garvin A J, Haber D A

机构信息

Laboratory of Molecular Genetics, Massachusetts General Hospital Cancer Center, Charlestown.

出版信息

Nat Genet. 1993 Dec;5(4):363-7. doi: 10.1038/ng1293-363.

DOI:10.1038/ng1293-363
PMID:8298644
Abstract

Nephrogenic rests consist of foci of primitive renal cells, typically microscopic, that are found within the normal kidney tissue of children with Wilms' tumour. To study the relationship between nephrogenic rests and the associated tumours, we screened these lesions for mutations in the 11p13 Wilms' tumour suppressor gene, WT1. In two cases in which the Wilms' tumour contained a somatic WT1 mutation, the nephrogenic rest had the identical mutation. Nephrogenic rests and Wilms' tumours are therefore topographically distinct lesions that are clonally derived from an early renal stem cell. Inactivation of WT1 appears to be an early genetic event which can lead to the formation of nephrogenic rests, enhancing the probability that additional genetic hits will lead to Wilms' tumour.

摘要

肾源性残留由原始肾细胞灶组成,通常为显微镜下可见,在患有威尔姆斯瘤的儿童正常肾组织中发现。为了研究肾源性残留与相关肿瘤之间的关系,我们筛查了这些病变中11p13威尔姆斯瘤抑制基因WT1的突变情况。在两例威尔姆斯瘤含有体细胞WT1突变的病例中,肾源性残留具有相同的突变。因此,肾源性残留和威尔姆斯瘤是在地形上不同的病变,它们克隆起源于早期肾干细胞。WT1的失活似乎是一个早期遗传事件,可导致肾源性残留的形成,增加了其他遗传打击导致威尔姆斯瘤的可能性。

相似文献

1
Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.肾源性残留(Wilms瘤的遗传前体)中WT1的失活。
Nat Genet. 1993 Dec;5(4):363-7. doi: 10.1038/ng1293-363.
2
Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.肾母细胞瘤中表达肾母细胞瘤基因(WT1)的细胞类型:对肿瘤组织发生的影响
Oncogene. 1991 Dec;6(12):2211-20.
3
Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.77例肾母细胞瘤中WT1基因的罕见突变
Hum Mutat. 1994;3(3):212-22. doi: 10.1002/humu.1380030307.
4
Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.剖析肾源性残留和肾母细胞瘤发生发展过程中的基因事件。
Am J Pathol. 1998 Sep;153(3):991-1000. doi: 10.1016/S0002-9440(10)65641-6.
5
Role of the WT1 gene in Wilms' tumour.WT1基因在肾母细胞瘤中的作用。
Cancer Surv. 1992;12:105-17.
6
Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.肾母细胞瘤的组织学由不同类型的前驱病变决定,而非表观遗传变化。
J Pathol. 2008 Aug;215(4):377-87. doi: 10.1002/path.2366.
7
WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.WT1:一种在肾母细胞瘤中失活的新型肿瘤抑制基因。
New Biol. 1992 Feb;4(2):97-106.
8
The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.肾母细胞瘤基因(WT1)产物在正常组织和小儿肾肿瘤中的表达模式。
J Pathol. 1996 Jun;179(2):162-8. doi: 10.1002/(SICI)1096-9896(199606)179:2<162::AID-PATH545>3.0.CO;2-0.
9
16q heterozygosity loss in Wilms' tumour in children and its clinical importance.儿童肾母细胞瘤中16号染色体长臂杂合性缺失及其临床意义。
Eur J Surg Oncol. 2000 Feb;26(1):61-6. doi: 10.1053/ejso.1999.0742.
10
Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.PAX2基因在人胎儿肾脏和肾母细胞瘤中的表达。
Cell Growth Differ. 1992 May;3(5):279-89.

引用本文的文献

1
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.EGFR 突变型肺癌伴发多原发肿瘤的发育嵌合体现象。
Nat Cancer. 2024 Nov;5(11):1681-1696. doi: 10.1038/s43018-024-00840-y. Epub 2024 Oct 15.
2
Characterization of Alternative Splicing in High-Risk Wilms' Tumors.高危肾母细胞瘤中可变剪接的特征分析
Int J Mol Sci. 2024 Apr 20;25(8):4520. doi: 10.3390/ijms25084520.
3
Somatic, Genetic and Epigenetic Changes in Nephrogenic Rests and Their Role in the Transformation to Wilms Tumors, a Systematic Review.
肾源性残留中的体细胞、遗传和表观遗传变化及其在向威尔姆斯瘤转化中的作用:一项系统综述
Cancers (Basel). 2023 Feb 21;15(5):1363. doi: 10.3390/cancers15051363.
4
MicroRNAs in kidney development and disease.微小 RNA 与肾脏发育和疾病。
JCI Insight. 2022 May 9;7(9):e158277. doi: 10.1172/jci.insight.158277.
5
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor.上皮剪接调节因子 ESRP2 在肾母细胞瘤中被 DNA 超甲基化表观遗传抑制,并作为肿瘤抑制因子发挥作用。
Mol Oncol. 2022 Feb;16(3):630-647. doi: 10.1002/1878-0261.13101. Epub 2021 Sep 28.
6
Immunohistochemical analysis of cyclin A expression in Wilms tumor.肾母细胞瘤中细胞周期蛋白A表达的免疫组织化学分析。
PeerJ. 2019 Jan 11;6:e6212. doi: 10.7717/peerj.6212. eCollection 2019.
7
Bilateral Wilms tumour: a review of clinical and molecular features.双侧肾母细胞瘤:临床与分子特征综述
Expert Rev Mol Med. 2017 Jul 18;19:e8. doi: 10.1017/erm.2017.8.
8
Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour.比较甲基组分析确定了新的肿瘤亚型和生物标志物,用于肾发育不良向肾母细胞瘤的转化。
Genome Med. 2015 Feb 2;7(1):11. doi: 10.1186/s13073-015-0136-4. eCollection 2015.
9
The yin and yang of kidney development and Wilms' tumors.肾脏发育与肾母细胞瘤的阴阳学说
Genes Dev. 2015 Mar 1;29(5):467-82. doi: 10.1101/gad.256396.114.
10
Glypican 3 overexpression in primary and metastatic Wilms tumors.磷脂酰肌醇蛋白聚糖3在原发性及转移性肾母细胞瘤中的过表达。
Virchows Arch. 2015 Jan;466(1):67-76. doi: 10.1007/s00428-014-1669-4. Epub 2014 Nov 4.